Perrigo Company Plc (NYSE:PRGO) Has Just Had Its Price Objective Increased by Equity Analysts at B. Riley to $241.00


Stock Analysis:Perrigo Company Plc (NYSE:PRGO) Price Target Change

In recent note made public by B. Riley on Friday morning, Perrigo Company Plc (NYSE:PRGO) had its target price per share increased to $241.00. The firm at present has a solid Buy rating on shares.

From a total of 14 analysts covering Perrigo Company Plc (NYSE:PRGO) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that NaN of the ratings are positive. The highest target price is $237 while the lowest target price is $156. The mean of all analyst targets is $190.71 with a 32.45% above today’s ($144.81) stock price. Perrigo Company Plc was the topic of 10 analyst reports since October 23, 2015 according to the firm StockzIntelligence Inc. Argus Research upgraded shares on December 10 to “Buy” rating. Deutsche Bank maintained shares with “Buy” rating and $187 target share price in a report from an October 23. B. Riley & Co maintained PRGO stock in a recent report from November 24 with “Buy” rating. Finally, UBS upgraded the stock to “Buy” rating in a report issued on a November 16.

Approximately 1.07 million shares of stock traded hands. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 24.80% since May 15, 2015 and is downtrending. It has underperformed by 20.99% the S&P500.

The overall sentiment of institutions has decreased to 0.82 in Q2 2015. Its down 0.03, from 0.85 in 2015Q2. The ratio dropped, as 92 institutions have sold all the shares of Perrigo Company plc Ordinary Shares that they owned while 197 funds have taken shares off the table. 40 funds have purchased shares for the first time while 197 added to their positions. These institutions now hold 92.93 million shares or 9.54% less than the 102.74 million shares they owned in 2015Q2.

The Fund Davide Leone & Partners Investment Co Llp currently is holding shares equating to 12.87% of its total portfolio in Perrigo Company plc Ordinary Shares representing a total of 550,500 shares. Another fund,Jet Capital Investors L P, is holding a total of 817,540 shares equating to 8.2% of their holdings. Additionally, Eton Park Capital Management L.P. has a 2.99 million share stake in Perrigo Company plc Ordinary Shares which represents 8.18% of their total portfolio. The Fund, Smithwood Advisers L.P., based out of California, has also built up a stake in the stock, which represents a total of 7.67% of their total portfolio. Finally Lg Capital Management Lp, a fund which is based in the state of Maryland reported a total holdings of 102,600 shares.

According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”